{
    "code": "10000757",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000757",
    "time": "2021-10-08 03:26:42",
    "許可證字號": "衛署菌疫輸字第000757號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/04\/22",
    "發證日期": "92\/02\/12",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA01000075704",
    "中文品名": "顆球諾得１００",
    "英文品名": "GRANOCYTE 100",
    "適應症": "1.促進造血幹細胞移植時的嗜中性白血球數的增加。2.癌症化學療法所引起之嗜中性白血球缺乏症。3.伴隨著骨髓發育不良症候群的嗜中性白血球減少症。4.先天性、特異性嗜中性白血球缺乏症。5.動員造血幹細胞至週邊血液中。",
    "劑型": "245凍晶乾燥注射劑",
    "包裝": "100μ每小瓶 100瓶以下盒裝 各附等支數公撮安瓿附溶液",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "LENOGRASTIM (GENETICAL RECOMBINATION)",
    "限制項目": "02輸　入",
    "申請商名稱": "1438501100  台灣中外製藥股份有限公司",
    "申請商地址": "台北市松山區敦化北路260號3樓",
    "主製造廠": [
        {
            "": "JAPAN",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FJP0533000  CHUGAI PHARMACEUTICAL CO., LTD.",
            "製造廠廠址": "5-1, UKIMA 5-CHOME, KITA-KU, TOKYO, JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "許可證持有者"
        },
        {
            "製造廠名稱": "FJP0533100  UKIMA PLANT OF CHUGAI PHARMA MANUFACTURING CO., LTD.",
            "製造廠廠址": "5-1, UKIMA 5-CHOME, KITA-KU, TOKYO JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "bulk"
        },
        {
            "製造廠名稱": "FJP0621100  Bushu Pharmaceuticals Ltd. Kawagoe Factory",
            "製造廠廠址": "1 Takeno, Kawagoe, Saitama, 350-0801, Japan",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FJP9444000  Nipro Pharma Corporation Ise Plant",
            "製造廠廠址": "647-240, Ureshinotengeji-cho, Matsusaka-shi, Mie 515-2302, Japan",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "注射用水製造"
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200035800",
            "成分名稱": "LENOGRASTIM (GENETICAL RECOMBINATION)",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MCG"
        }
    ],
    "仿單外盒": [
        {
            "title": "顆球諾得-仿單-107-12-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000757&Seq=026&Type=9"
        },
        {
            "title": "顆球諾得16.0(20180312)-107-03-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000757&Seq=025&Type=9"
        },
        {
            "title": "GRANOCYTE注射用水標籤-106-12-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000757&Seq=007&Type=8"
        },
        {
            "title": "0914-GRANOCYTE 100台灣標籤-106-12-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000757&Seq=006&Type=8"
        },
        {
            "title": "0914-GRANOCYTE 100台灣外盒-106-12-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000757&Seq=005&Type=8"
        }
    ]
}